NRX Pharmaceuticals Inc. Gains 51.57%
Fri, Jul 29, 2022 at 06:58 PM
NRX Pharmaceuticals Inc. (NRXP:NASDAQ) jumped higher at $0.79, representing a gain of 51.6%. On Fri, Jul 29, 2022, NRXP:NASDAQ touched a New 2-Week High of $0.79. The stock appeared on our News Catalysts scanner on Fri, Jul 01, 2022 at 08:21 AM in the 'BIOTECH' category. From Fri, Jul 15, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Jul 29, 2022 at $1.05 with a volume of 104M+.
About NRX Pharmaceuticals Inc. (NRXP:NASDAQ)
NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening...
Top 10 Gainers:
- Getty Images Holdings Inc. Class A (GETY:NYSE), 149.05%
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 122.36%
- Senti Biosciences Inc Com (SNTI:NASDAQ), 68.28%
- NRX Pharmaceuticals Inc. (NRXP:NASDAQ), 51.57%
- Meihua International Medical Technologies Co. Ltd. (MHUA:NASDAQ), 40.24%
- Pagaya Technologies Ltd. (PGY:NASDAQ), 38.12%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 28.65%
- ThermoGenesis Holdings, Inc. (THMO:NASDAQ), 26.96%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 26.76%
- AXT, Inc. (AXTI:NASDAQ), 24.93%